相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Follicular lymphoma: The long and winding road leading to your cure?
Max J. Gordon et al.
BLOOD REVIEWS (2023)
Time for an individualized approach to first-line management of follicular lymphoma
Guillaume Cartron et al.
HAEMATOLOGICA (2022)
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials
Carla Casulo et al.
BLOOD (2022)
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy
Claire M. Patterson et al.
COMMUNICATIONS BIOLOGY (2021)
Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation
Emil Kumar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Follicular lymphoma: is there an optimal way to define risk?
Carla Casulo
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2021)
Past, present and future of prognostic scores in follicular lymphoma
Pablo Mozas et al.
BLOOD REVIEWS (2021)
High-risk follicular lymphoma: Treatment options
Brad Kahl
HEMATOLOGICAL ONCOLOGY (2021)
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era
Arushi Khurana et al.
BLOOD CANCER JOURNAL (2021)
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy
Sandra Lockmer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Epidemiology of Follicular Lymphoma
James R. Cerhan
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2020)
How to manage early-stage follicular lymphoma
Emanuele Cencini et al.
EXPERT REVIEW OF HEMATOLOGY (2020)
Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemotherapy
Vindi Jurinovic et al.
BLOOD (2019)
Follicular lymphoma
Antonino Carbone et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
Massimo Federico et al.
LANCET HAEMATOLOGY (2018)
Past, Present, and Future of Rituximab-The world's First Oncology Monoclonal Antibody Therapy
Timothy M. Pierpont et al.
FRONTIERS IN ONCOLOGY (2018)
From genetics to the clinic: a translational perspective on follicular lymphoma
Sarah Huet et al.
NATURE REVIEWS CANCER (2018)
Where to start? Upfront therapy for follicular lymphoma in 2018
John P. Leonard et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
James R. Cerhan et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab
Sarah Huet et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
Matthew J. Maurer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Follicular lymphoma: evolving therapeutic strategies
Brad S. Kahl et al.
BLOOD (2016)
Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Javeed Iqbal et al.
BLOOD REVIEWS (2016)
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study
Robert Kridel et al.
PLOS MEDICINE (2016)
Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity
Rafael Casellas et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Carla Casulo et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
Alessandro Pastore et al.
LANCET ONCOLOGY (2015)
AID targeting: old mysteries and new challenges
Vivek Chandra et al.
TRENDS IN IMMUNOLOGY (2015)
BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma
Cristina Correia et al.
BLOOD (2015)
The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation
Jean-Pierre A. Kocher et al.
BIOINFORMATICS (2014)
Rituximab Extended Schedule or Re-Treatment Trial for Low-Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402
Brad S. Kahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Rituximab versus a watch-and-wait approach in patients with advanced- stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
Kirit M. Ardeshna et al.
LANCET ONCOLOGY (2014)
Follicular lymphoma: watch and wait is watch and worry
Stephen M. Ansell
LANCET ONCOLOGY (2014)
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
Jessica Okosun et al.
NATURE GENETICS (2014)
Genetics of Follicular Lymphoma Transformation
Laura Pasqualucci et al.
CELL REPORTS (2014)
Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource
Brian K. Link et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
An integrated map of genetic variation from 1,092 human genomes
David M. Altshuler et al.
NATURE (2012)
Btrim: A fast, lightweight adapter and quality trimming program for next-generation sequencing technologies
Yong Kong
GENOMICS (2011)
BEDTools: a flexible suite of utilities for comparing genomic features
Aaron R. Quinlan et al.
BIOINFORMATICS (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era
Grzegorz S. Nowakowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A map of human genome variation from population-scale sequencing
David Altshuler et al.
NATURE (2010)
Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants
Yingrui Li et al.
NATURE GENETICS (2010)
The involvement of mitochondria and the caspase-9 activation pathway in rituximab-induced apoptosis in FL cells
Jonna Eeva et al.
APOPTOSIS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma
Anna Margret Halldorsdottir et al.
LEUKEMIA RESEARCH (2008)
Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma
C Bödör et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL
MS Hardianti et al.
LEUKEMIA (2004)